nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—GPRC5A—digestive system—Crohn's disease	0.0205	0.0758	CbGeAlD
Tretinoin—CRABP2—mouth—Crohn's disease	0.0157	0.058	CbGeAlD
Tretinoin—ALDH1A1—gall bladder—Crohn's disease	0.0147	0.0543	CbGeAlD
Tretinoin—ALDH1A1—mouth—Crohn's disease	0.0131	0.0483	CbGeAlD
Tretinoin—RARRES1—skin of body—Crohn's disease	0.013	0.0479	CbGeAlD
Tretinoin—RARRES1—mammalian vulva—Crohn's disease	0.0118	0.0437	CbGeAlD
Tretinoin—RARG—mouth—Crohn's disease	0.0115	0.0423	CbGeAlD
Tretinoin—CRABP1—skin of body—Crohn's disease	0.00961	0.0355	CbGeAlD
Tretinoin—CRABP2—smooth muscle tissue—Crohn's disease	0.0088	0.0325	CbGeAlD
Tretinoin—CRABP1—mammalian vulva—Crohn's disease	0.00876	0.0324	CbGeAlD
Tretinoin—CRABP2—skin of body—Crohn's disease	0.00869	0.0321	CbGeAlD
Tretinoin—CRABP2—mammalian vulva—Crohn's disease	0.00792	0.0293	CbGeAlD
Tretinoin—CYP4A11—digestive system—Crohn's disease	0.00769	0.0284	CbGeAlD
Tretinoin—ALDH1A1—smooth muscle tissue—Crohn's disease	0.00734	0.0271	CbGeAlD
Tretinoin—ALDH1A1—skin of body—Crohn's disease	0.00724	0.0267	CbGeAlD
Tretinoin—CRABP2—digestive system—Crohn's disease	0.00695	0.0257	CbGeAlD
Tretinoin—ALDH1A1—mammalian vulva—Crohn's disease	0.0066	0.0244	CbGeAlD
Tretinoin—RARG—skin of body—Crohn's disease	0.00634	0.0234	CbGeAlD
Tretinoin—RARRES1—lymph node—Crohn's disease	0.00593	0.0219	CbGeAlD
Tretinoin—ALDH1A1—lymphoid tissue—Crohn's disease	0.00586	0.0217	CbGeAlD
Tretinoin—CYP2C18—mammalian vulva—Crohn's disease	0.0058	0.0214	CbGeAlD
Tretinoin—ALDH1A1—digestive system—Crohn's disease	0.00579	0.0214	CbGeAlD
Tretinoin—RARG—mammalian vulva—Crohn's disease	0.00578	0.0213	CbGeAlD
Tretinoin—CYP2C18—digestive system—Crohn's disease	0.00509	0.0188	CbGeAlD
Tretinoin—RARG—digestive system—Crohn's disease	0.00507	0.0187	CbGeAlD
Tretinoin—RARA—lymphoid tissue—Crohn's disease	0.00483	0.0178	CbGeAlD
Tretinoin—ALDH1A2—lymph node—Crohn's disease	0.00455	0.0168	CbGeAlD
Tretinoin—CYP1A1—mouth—Crohn's disease	0.00394	0.0145	CbGeAlD
Tretinoin—RARB—lymph node—Crohn's disease	0.00355	0.0131	CbGeAlD
Tretinoin—ALDH1A1—lymph node—Crohn's disease	0.00331	0.0122	CbGeAlD
Tretinoin—RARG—lymph node—Crohn's disease	0.0029	0.0107	CbGeAlD
Tretinoin—RARA—lymph node—Crohn's disease	0.00272	0.0101	CbGeAlD
Tretinoin—CYP1A1—epithelium—Crohn's disease	0.00229	0.00846	CbGeAlD
Tretinoin—CYP1A1—skin of body—Crohn's disease	0.00218	0.00805	CbGeAlD
Tretinoin—CYP2B6—skin of body—Crohn's disease	0.00212	0.00782	CbGeAlD
Tretinoin—CYP1A1—mammalian vulva—Crohn's disease	0.00199	0.00734	CbGeAlD
Tretinoin—CYP1A1—digestive system—Crohn's disease	0.00174	0.00644	CbGeAlD
Tretinoin—CYP2B6—lymphoid tissue—Crohn's disease	0.00172	0.00633	CbGeAlD
Tretinoin—CYP3A5—digestive system—Crohn's disease	0.0017	0.0063	CbGeAlD
Tretinoin—CYP2B6—digestive system—Crohn's disease	0.00169	0.00626	CbGeAlD
Tretinoin—CYP2C9—digestive system—Crohn's disease	0.00168	0.0062	CbGeAlD
Tretinoin—Blood creatinine increased—Mesalazine—Crohn's disease	0.00145	0.00216	CcSEcCtD
Tretinoin—Pancreatitis—Azathioprine—Crohn's disease	0.00144	0.00214	CcSEcCtD
Tretinoin—Memory impairment—Prednisone—Crohn's disease	0.00143	0.00214	CcSEcCtD
Tretinoin—Dry skin—Mesalazine—Crohn's disease	0.00141	0.00211	CcSEcCtD
Tretinoin—Abdominal discomfort—Azathioprine—Crohn's disease	0.0014	0.00209	CcSEcCtD
Tretinoin—Oedema—Mercaptopurine—Crohn's disease	0.0014	0.00208	CcSEcCtD
Tretinoin—Nasopharyngitis—Mesalazine—Crohn's disease	0.00138	0.00206	CcSEcCtD
Tretinoin—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00137	0.00204	CcSEcCtD
Tretinoin—Gastritis—Mesalazine—Crohn's disease	0.00137	0.00204	CcSEcCtD
Tretinoin—Skin disorder—Mercaptopurine—Crohn's disease	0.00136	0.00202	CcSEcCtD
Tretinoin—Abdominal distension—Mesalazine—Crohn's disease	0.00134	0.002	CcSEcCtD
Tretinoin—Acne—Prednisone—Crohn's disease	0.00134	0.00199	CcSEcCtD
Tretinoin—Asthma—Mesalazine—Crohn's disease	0.00133	0.00199	CcSEcCtD
Tretinoin—Dysphagia—Mesalazine—Crohn's disease	0.00133	0.00199	CcSEcCtD
Tretinoin—Anorexia—Mercaptopurine—Crohn's disease	0.00133	0.00199	CcSEcCtD
Tretinoin—Pneumonia—Azathioprine—Crohn's disease	0.00131	0.00196	CcSEcCtD
Tretinoin—Bronchospasm—Mesalazine—Crohn's disease	0.00131	0.00196	CcSEcCtD
Tretinoin—Pancreatitis—Mesalazine—Crohn's disease	0.00131	0.00195	CcSEcCtD
Tretinoin—Infestation NOS—Azathioprine—Crohn's disease	0.00131	0.00195	CcSEcCtD
Tretinoin—Infestation—Azathioprine—Crohn's disease	0.00131	0.00195	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00129	0.00193	CcSEcCtD
Tretinoin—Contusion—Prednisone—Crohn's disease	0.00129	0.00192	CcSEcCtD
Tretinoin—CYP3A4—digestive system—Crohn's disease	0.00128	0.00472	CbGeAlD
Tretinoin—Abdominal discomfort—Mesalazine—Crohn's disease	0.00128	0.00191	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00127	0.0019	CcSEcCtD
Tretinoin—Dysuria—Mesalazine—Crohn's disease	0.00125	0.00186	CcSEcCtD
Tretinoin—Neutropenia—Mesalazine—Crohn's disease	0.00125	0.00186	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00124	0.00185	CcSEcCtD
Tretinoin—Pollakiuria—Mesalazine—Crohn's disease	0.00123	0.00184	CcSEcCtD
Tretinoin—Agranulocytosis—Azathioprine—Crohn's disease	0.00122	0.00182	CcSEcCtD
Tretinoin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00122	0.00181	CcSEcCtD
Tretinoin—Decreased appetite—Mercaptopurine—Crohn's disease	0.00122	0.00181	CcSEcCtD
Tretinoin—Weight increased—Mesalazine—Crohn's disease	0.00121	0.00181	CcSEcCtD
Tretinoin—Weight decreased—Mesalazine—Crohn's disease	0.00121	0.0018	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00121	0.0018	CcSEcCtD
Tretinoin—Leukocytosis—Prednisone—Crohn's disease	0.0012	0.00178	CcSEcCtD
Tretinoin—Pneumonia—Mesalazine—Crohn's disease	0.0012	0.00178	CcSEcCtD
Tretinoin—Infestation NOS—Mesalazine—Crohn's disease	0.00119	0.00177	CcSEcCtD
Tretinoin—Infestation—Mesalazine—Crohn's disease	0.00119	0.00177	CcSEcCtD
Tretinoin—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00119	0.00177	CcSEcCtD
Tretinoin—Ulcer—Prednisone—Crohn's disease	0.00119	0.00177	CcSEcCtD
Tretinoin—Depression—Mesalazine—Crohn's disease	0.00119	0.00177	CcSEcCtD
Tretinoin—Cataract—Prednisone—Crohn's disease	0.00118	0.00176	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00118	0.00176	CcSEcCtD
Tretinoin—Haemoglobin—Azathioprine—Crohn's disease	0.00118	0.00176	CcSEcCtD
Tretinoin—Haemorrhage—Azathioprine—Crohn's disease	0.00117	0.00175	CcSEcCtD
Tretinoin—Renal failure—Mesalazine—Crohn's disease	0.00117	0.00174	CcSEcCtD
Tretinoin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00117	0.00174	CcSEcCtD
Tretinoin—Stomatitis—Mesalazine—Crohn's disease	0.00116	0.00173	CcSEcCtD
Tretinoin—Conjunctivitis—Mesalazine—Crohn's disease	0.00116	0.00172	CcSEcCtD
Tretinoin—Urinary tract infection—Mesalazine—Crohn's disease	0.00116	0.00172	CcSEcCtD
Tretinoin—Vasculitis—Prednisone—Crohn's disease	0.00115	0.00172	CcSEcCtD
Tretinoin—Sweating—Mesalazine—Crohn's disease	0.00114	0.0017	CcSEcCtD
Tretinoin—Haematuria—Mesalazine—Crohn's disease	0.00113	0.00169	CcSEcCtD
Tretinoin—Epistaxis—Mesalazine—Crohn's disease	0.00112	0.00167	CcSEcCtD
Tretinoin—Sinusitis—Mesalazine—Crohn's disease	0.00112	0.00166	CcSEcCtD
Tretinoin—Agranulocytosis—Mesalazine—Crohn's disease	0.00111	0.00165	CcSEcCtD
Tretinoin—Erythema multiforme—Azathioprine—Crohn's disease	0.00111	0.00165	CcSEcCtD
Tretinoin—Body temperature increased—Mercaptopurine—Crohn's disease	0.00111	0.00165	CcSEcCtD
Tretinoin—Skin exfoliation—Prednisone—Crohn's disease	0.00107	0.0016	CcSEcCtD
Tretinoin—Haemoglobin—Mesalazine—Crohn's disease	0.00107	0.0016	CcSEcCtD
Tretinoin—Hepatitis—Mesalazine—Crohn's disease	0.00107	0.00159	CcSEcCtD
Tretinoin—Haemorrhage—Mesalazine—Crohn's disease	0.00107	0.00159	CcSEcCtD
Tretinoin—Pharyngitis—Mesalazine—Crohn's disease	0.00106	0.00158	CcSEcCtD
Tretinoin—Urinary tract disorder—Mesalazine—Crohn's disease	0.00105	0.00157	CcSEcCtD
Tretinoin—Oedema peripheral—Mesalazine—Crohn's disease	0.00105	0.00157	CcSEcCtD
Tretinoin—Chills—Azathioprine—Crohn's disease	0.00105	0.00157	CcSEcCtD
Tretinoin—Arrhythmia—Azathioprine—Crohn's disease	0.00105	0.00156	CcSEcCtD
Tretinoin—Urethral disorder—Mesalazine—Crohn's disease	0.00105	0.00156	CcSEcCtD
Tretinoin—Alopecia—Azathioprine—Crohn's disease	0.00104	0.00154	CcSEcCtD
Tretinoin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00103	0.00153	CcSEcCtD
Tretinoin—Oesophagitis—Prednisone—Crohn's disease	0.00103	0.00153	CcSEcCtD
Tretinoin—Erythema multiforme—Mesalazine—Crohn's disease	0.00101	0.0015	CcSEcCtD
Tretinoin—Pulmonary oedema—Prednisone—Crohn's disease	0.001	0.00149	CcSEcCtD
Tretinoin—Eye disorder—Mesalazine—Crohn's disease	0.000998	0.00149	CcSEcCtD
Tretinoin—CYP1A1—lymph node—Crohn's disease	0.000996	0.00368	CbGeAlD
Tretinoin—Tinnitus—Mesalazine—Crohn's disease	0.000996	0.00148	CcSEcCtD
Tretinoin—Sepsis—Prednisone—Crohn's disease	0.000976	0.00146	CcSEcCtD
Tretinoin—Angiopathy—Mesalazine—Crohn's disease	0.000969	0.00144	CcSEcCtD
Tretinoin—Euphoric mood—Prednisone—Crohn's disease	0.000967	0.00144	CcSEcCtD
Tretinoin—Chills—Mesalazine—Crohn's disease	0.000958	0.00143	CcSEcCtD
Tretinoin—Diarrhoea—Mercaptopurine—Crohn's disease	0.000956	0.00143	CcSEcCtD
Tretinoin—Ill-defined disorder—Azathioprine—Crohn's disease	0.000947	0.00141	CcSEcCtD
Tretinoin—Alopecia—Mesalazine—Crohn's disease	0.000944	0.00141	CcSEcCtD
Tretinoin—Anaemia—Azathioprine—Crohn's disease	0.000943	0.00141	CcSEcCtD
Tretinoin—Diabetes mellitus—Prednisone—Crohn's disease	0.000939	0.0014	CcSEcCtD
Tretinoin—Mental disorder—Mesalazine—Crohn's disease	0.000936	0.00139	CcSEcCtD
Tretinoin—Erythema—Mesalazine—Crohn's disease	0.00093	0.00139	CcSEcCtD
Tretinoin—Malaise—Azathioprine—Crohn's disease	0.00092	0.00137	CcSEcCtD
Tretinoin—Flatulence—Mesalazine—Crohn's disease	0.000916	0.00137	CcSEcCtD
Tretinoin—Tension—Mesalazine—Crohn's disease	0.000912	0.00136	CcSEcCtD
Tretinoin—Nervousness—Mesalazine—Crohn's disease	0.000903	0.00135	CcSEcCtD
Tretinoin—Cardiac failure congestive—Prednisone—Crohn's disease	0.000901	0.00134	CcSEcCtD
Tretinoin—Back pain—Mesalazine—Crohn's disease	0.000899	0.00134	CcSEcCtD
Tretinoin—Vomiting—Mercaptopurine—Crohn's disease	0.000889	0.00132	CcSEcCtD
Tretinoin—Rash—Mercaptopurine—Crohn's disease	0.000881	0.00131	CcSEcCtD
Tretinoin—Dermatitis—Mercaptopurine—Crohn's disease	0.000881	0.00131	CcSEcCtD
Tretinoin—Vision blurred—Mesalazine—Crohn's disease	0.000876	0.00131	CcSEcCtD
Tretinoin—Tremor—Mesalazine—Crohn's disease	0.000871	0.0013	CcSEcCtD
Tretinoin—Arthralgia—Azathioprine—Crohn's disease	0.000869	0.00129	CcSEcCtD
Tretinoin—Myalgia—Azathioprine—Crohn's disease	0.000869	0.00129	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000863	0.00129	CcSEcCtD
Tretinoin—Ill-defined disorder—Mesalazine—Crohn's disease	0.000862	0.00129	CcSEcCtD
Tretinoin—Anaemia—Mesalazine—Crohn's disease	0.000859	0.00128	CcSEcCtD
Tretinoin—Discomfort—Azathioprine—Crohn's disease	0.000858	0.00128	CcSEcCtD
Tretinoin—Malaise—Mesalazine—Crohn's disease	0.000838	0.00125	CcSEcCtD
Tretinoin—Cardiac failure—Prednisone—Crohn's disease	0.000837	0.00125	CcSEcCtD
Tretinoin—Syncope—Mesalazine—Crohn's disease	0.000834	0.00124	CcSEcCtD
Tretinoin—Lethargy—Prednisone—Crohn's disease	0.000833	0.00124	CcSEcCtD
Tretinoin—Nausea—Mercaptopurine—Crohn's disease	0.00083	0.00124	CcSEcCtD
Tretinoin—Infection—Azathioprine—Crohn's disease	0.000827	0.00123	CcSEcCtD
Tretinoin—Palpitations—Mesalazine—Crohn's disease	0.000821	0.00122	CcSEcCtD
Tretinoin—Loss of consciousness—Mesalazine—Crohn's disease	0.000817	0.00122	CcSEcCtD
Tretinoin—Osteoarthritis—Prednisone—Crohn's disease	0.000817	0.00122	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000817	0.00122	CcSEcCtD
Tretinoin—Thrombocytopenia—Azathioprine—Crohn's disease	0.000815	0.00122	CcSEcCtD
Tretinoin—Cough—Mesalazine—Crohn's disease	0.000811	0.00121	CcSEcCtD
Tretinoin—Skin disorder—Azathioprine—Crohn's disease	0.000809	0.00121	CcSEcCtD
Tretinoin—Affect lability—Prednisone—Crohn's disease	0.000804	0.0012	CcSEcCtD
Tretinoin—Hypertension—Mesalazine—Crohn's disease	0.000803	0.0012	CcSEcCtD
Tretinoin—Psychotic disorder—Prednisone—Crohn's disease	0.000798	0.00119	CcSEcCtD
Tretinoin—Myalgia—Mesalazine—Crohn's disease	0.000791	0.00118	CcSEcCtD
Tretinoin—Chest pain—Mesalazine—Crohn's disease	0.000791	0.00118	CcSEcCtD
Tretinoin—Arthralgia—Mesalazine—Crohn's disease	0.000791	0.00118	CcSEcCtD
Tretinoin—Anxiety—Mesalazine—Crohn's disease	0.000789	0.00118	CcSEcCtD
Tretinoin—Face oedema—Prednisone—Crohn's disease	0.000788	0.00118	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000786	0.00117	CcSEcCtD
Tretinoin—Discomfort—Mesalazine—Crohn's disease	0.000782	0.00117	CcSEcCtD
Tretinoin—Irritability—Prednisone—Crohn's disease	0.000779	0.00116	CcSEcCtD
Tretinoin—Hypotension—Azathioprine—Crohn's disease	0.000778	0.00116	CcSEcCtD
Tretinoin—Cardiac arrest—Prednisone—Crohn's disease	0.000777	0.00116	CcSEcCtD
Tretinoin—Dry mouth—Mesalazine—Crohn's disease	0.000774	0.00115	CcSEcCtD
Tretinoin—Mood swings—Prednisone—Crohn's disease	0.000774	0.00115	CcSEcCtD
Tretinoin—Confusional state—Mesalazine—Crohn's disease	0.000765	0.00114	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000759	0.00113	CcSEcCtD
Tretinoin—Anaphylactic shock—Mesalazine—Crohn's disease	0.000759	0.00113	CcSEcCtD
Tretinoin—Oedema—Mesalazine—Crohn's disease	0.000759	0.00113	CcSEcCtD
Tretinoin—Infection—Mesalazine—Crohn's disease	0.000754	0.00112	CcSEcCtD
Tretinoin—Dry skin—Prednisone—Crohn's disease	0.000749	0.00112	CcSEcCtD
Tretinoin—Shock—Mesalazine—Crohn's disease	0.000746	0.00111	CcSEcCtD
Tretinoin—Nervous system disorder—Mesalazine—Crohn's disease	0.000744	0.00111	CcSEcCtD
Tretinoin—Thrombocytopenia—Mesalazine—Crohn's disease	0.000743	0.00111	CcSEcCtD
Tretinoin—Tachycardia—Mesalazine—Crohn's disease	0.00074	0.0011	CcSEcCtD
Tretinoin—Skin disorder—Mesalazine—Crohn's disease	0.000737	0.0011	CcSEcCtD
Tretinoin—Hyperhidrosis—Mesalazine—Crohn's disease	0.000733	0.00109	CcSEcCtD
Tretinoin—Anorexia—Mesalazine—Crohn's disease	0.000723	0.00108	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000719	0.00107	CcSEcCtD
Tretinoin—Abdominal distension—Prednisone—Crohn's disease	0.000711	0.00106	CcSEcCtD
Tretinoin—Hypotension—Mesalazine—Crohn's disease	0.000709	0.00106	CcSEcCtD
Tretinoin—Pancreatitis—Prednisone—Crohn's disease	0.000692	0.00103	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000691	0.00103	CcSEcCtD
Tretinoin—Sweating increased—Prednisone—Crohn's disease	0.000688	0.00102	CcSEcCtD
Tretinoin—Feeling abnormal—Azathioprine—Crohn's disease	0.000686	0.00102	CcSEcCtD
Tretinoin—Insomnia—Mesalazine—Crohn's disease	0.000686	0.00102	CcSEcCtD
Tretinoin—Paraesthesia—Mesalazine—Crohn's disease	0.000681	0.00102	CcSEcCtD
Tretinoin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000681	0.00102	CcSEcCtD
Tretinoin—Dyspnoea—Mesalazine—Crohn's disease	0.000676	0.00101	CcSEcCtD
Tretinoin—Somnolence—Mesalazine—Crohn's disease	0.000674	0.00101	CcSEcCtD
Tretinoin—Dyspepsia—Mesalazine—Crohn's disease	0.000668	0.000995	CcSEcCtD
Tretinoin—Neutropenia—Prednisone—Crohn's disease	0.00066	0.000984	CcSEcCtD
Tretinoin—Decreased appetite—Mesalazine—Crohn's disease	0.00066	0.000983	CcSEcCtD
Tretinoin—Body temperature increased—Azathioprine—Crohn's disease	0.000658	0.000981	CcSEcCtD
Tretinoin—Abdominal pain—Azathioprine—Crohn's disease	0.000658	0.000981	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000655	0.000976	CcSEcCtD
Tretinoin—Fatigue—Mesalazine—Crohn's disease	0.000654	0.000975	CcSEcCtD
Tretinoin—Pain—Mesalazine—Crohn's disease	0.000649	0.000967	CcSEcCtD
Tretinoin—Constipation—Mesalazine—Crohn's disease	0.000649	0.000967	CcSEcCtD
Tretinoin—Weight increased—Prednisone—Crohn's disease	0.000642	0.000957	CcSEcCtD
Tretinoin—Weight decreased—Prednisone—Crohn's disease	0.000639	0.000952	CcSEcCtD
Tretinoin—Depression—Prednisone—Crohn's disease	0.000628	0.000935	CcSEcCtD
Tretinoin—Feeling abnormal—Mesalazine—Crohn's disease	0.000625	0.000932	CcSEcCtD
Tretinoin—Acute coronary syndrome—Prednisone—Crohn's disease	0.00062	0.000925	CcSEcCtD
Tretinoin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00062	0.000925	CcSEcCtD
Tretinoin—Neuropathy peripheral—Prednisone—Crohn's disease	0.000617	0.000919	CcSEcCtD
Tretinoin—Myocardial infarction—Prednisone—Crohn's disease	0.000617	0.000919	CcSEcCtD
Tretinoin—Hypersensitivity—Azathioprine—Crohn's disease	0.000614	0.000915	CcSEcCtD
Tretinoin—Urticaria—Mesalazine—Crohn's disease	0.000603	0.000898	CcSEcCtD
Tretinoin—Body temperature increased—Mesalazine—Crohn's disease	0.0006	0.000894	CcSEcCtD
Tretinoin—Abdominal pain—Mesalazine—Crohn's disease	0.0006	0.000894	CcSEcCtD
Tretinoin—Diarrhoea—Azathioprine—Crohn's disease	0.00057	0.000849	CcSEcCtD
Tretinoin—Haemoglobin—Prednisone—Crohn's disease	0.000568	0.000846	CcSEcCtD
Tretinoin—Haemorrhage—Prednisone—Crohn's disease	0.000565	0.000842	CcSEcCtD
Tretinoin—Hallucination—Prednisone—Crohn's disease	0.000562	0.000838	CcSEcCtD
Tretinoin—Hypersensitivity—Mesalazine—Crohn's disease	0.000559	0.000833	CcSEcCtD
Tretinoin—Dizziness—Azathioprine—Crohn's disease	0.000551	0.000821	CcSEcCtD
Tretinoin—Asthenia—Mesalazine—Crohn's disease	0.000544	0.000811	CcSEcCtD
Tretinoin—Pruritus—Mesalazine—Crohn's disease	0.000537	0.0008	CcSEcCtD
Tretinoin—Vomiting—Azathioprine—Crohn's disease	0.00053	0.000789	CcSEcCtD
Tretinoin—Eye disorder—Prednisone—Crohn's disease	0.000528	0.000787	CcSEcCtD
Tretinoin—Rash—Azathioprine—Crohn's disease	0.000525	0.000783	CcSEcCtD
Tretinoin—Dermatitis—Azathioprine—Crohn's disease	0.000525	0.000782	CcSEcCtD
Tretinoin—Flushing—Prednisone—Crohn's disease	0.000524	0.000781	CcSEcCtD
Tretinoin—Headache—Azathioprine—Crohn's disease	0.000522	0.000778	CcSEcCtD
Tretinoin—Diarrhoea—Mesalazine—Crohn's disease	0.000519	0.000774	CcSEcCtD
Tretinoin—Angiopathy—Prednisone—Crohn's disease	0.000513	0.000764	CcSEcCtD
Tretinoin—Arrhythmia—Prednisone—Crohn's disease	0.000505	0.000752	CcSEcCtD
Tretinoin—Dizziness—Mesalazine—Crohn's disease	0.000502	0.000748	CcSEcCtD
Tretinoin—Alopecia—Prednisone—Crohn's disease	0.000499	0.000744	CcSEcCtD
Tretinoin—Mental disorder—Prednisone—Crohn's disease	0.000495	0.000738	CcSEcCtD
Tretinoin—Nausea—Azathioprine—Crohn's disease	0.000495	0.000737	CcSEcCtD
Tretinoin—Erythema—Prednisone—Crohn's disease	0.000492	0.000733	CcSEcCtD
Tretinoin—Malnutrition—Prednisone—Crohn's disease	0.000492	0.000733	CcSEcCtD
Tretinoin—Vomiting—Mesalazine—Crohn's disease	0.000482	0.000719	CcSEcCtD
Tretinoin—Rash—Mesalazine—Crohn's disease	0.000478	0.000713	CcSEcCtD
Tretinoin—Dermatitis—Mesalazine—Crohn's disease	0.000478	0.000712	CcSEcCtD
Tretinoin—Headache—Mesalazine—Crohn's disease	0.000475	0.000708	CcSEcCtD
Tretinoin—Vision blurred—Prednisone—Crohn's disease	0.000464	0.000691	CcSEcCtD
Tretinoin—Ill-defined disorder—Prednisone—Crohn's disease	0.000456	0.00068	CcSEcCtD
Tretinoin—Anaemia—Prednisone—Crohn's disease	0.000455	0.000677	CcSEcCtD
Tretinoin—Agitation—Prednisone—Crohn's disease	0.000452	0.000674	CcSEcCtD
Tretinoin—Nausea—Mesalazine—Crohn's disease	0.000451	0.000672	CcSEcCtD
Tretinoin—Malaise—Prednisone—Crohn's disease	0.000444	0.000661	CcSEcCtD
Tretinoin—Syncope—Prednisone—Crohn's disease	0.000441	0.000657	CcSEcCtD
Tretinoin—Loss of consciousness—Prednisone—Crohn's disease	0.000432	0.000644	CcSEcCtD
Tretinoin—Convulsion—Prednisone—Crohn's disease	0.000426	0.000635	CcSEcCtD
Tretinoin—Hypertension—Prednisone—Crohn's disease	0.000425	0.000633	CcSEcCtD
Tretinoin—Myalgia—Prednisone—Crohn's disease	0.000419	0.000624	CcSEcCtD
Tretinoin—Arthralgia—Prednisone—Crohn's disease	0.000419	0.000624	CcSEcCtD
Tretinoin—Anxiety—Prednisone—Crohn's disease	0.000417	0.000622	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000416	0.00062	CcSEcCtD
Tretinoin—Discomfort—Prednisone—Crohn's disease	0.000414	0.000617	CcSEcCtD
Tretinoin—Oedema—Prednisone—Crohn's disease	0.000401	0.000598	CcSEcCtD
Tretinoin—Anaphylactic shock—Prednisone—Crohn's disease	0.000401	0.000598	CcSEcCtD
Tretinoin—Infection—Prednisone—Crohn's disease	0.000399	0.000594	CcSEcCtD
Tretinoin—Shock—Prednisone—Crohn's disease	0.000395	0.000589	CcSEcCtD
Tretinoin—Nervous system disorder—Prednisone—Crohn's disease	0.000394	0.000587	CcSEcCtD
Tretinoin—Tachycardia—Prednisone—Crohn's disease	0.000392	0.000584	CcSEcCtD
Tretinoin—Skin disorder—Prednisone—Crohn's disease	0.00039	0.000581	CcSEcCtD
Tretinoin—Hyperhidrosis—Prednisone—Crohn's disease	0.000388	0.000578	CcSEcCtD
Tretinoin—Anorexia—Prednisone—Crohn's disease	0.000383	0.00057	CcSEcCtD
Tretinoin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Crohn's disease	0.00038	0.00653	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—SMAD3—Crohn's disease	0.000369	0.00634	CbGpPWpGaD
Tretinoin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000366	0.000545	CcSEcCtD
Tretinoin—Insomnia—Prednisone—Crohn's disease	0.000363	0.000541	CcSEcCtD
Tretinoin—Paraesthesia—Prednisone—Crohn's disease	0.00036	0.000537	CcSEcCtD
Tretinoin—Dyspepsia—Prednisone—Crohn's disease	0.000353	0.000527	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000352	0.00605	CbGpPWpGaD
Tretinoin—Decreased appetite—Prednisone—Crohn's disease	0.000349	0.00052	CcSEcCtD
Tretinoin—RARA—Adipogenesis—SMAD3—Crohn's disease	0.000347	0.00597	CbGpPWpGaD
Tretinoin—Fatigue—Prednisone—Crohn's disease	0.000346	0.000516	CcSEcCtD
Tretinoin—Constipation—Prednisone—Crohn's disease	0.000343	0.000512	CcSEcCtD
Tretinoin—CYP2C18—Metapathway biotransformation—GPX4—Crohn's disease	0.000342	0.00588	CbGpPWpGaD
Tretinoin—RXRA—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000338	0.00581	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000337	0.0058	CbGpPWpGaD
Tretinoin—Feeling abnormal—Prednisone—Crohn's disease	0.000331	0.000493	CcSEcCtD
Tretinoin—RARG—Gene Expression—PTRF—Crohn's disease	0.000329	0.00565	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Prednisone—Crohn's disease	0.000328	0.000489	CcSEcCtD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.000324	0.00557	CbGpPWpGaD
Tretinoin—Urticaria—Prednisone—Crohn's disease	0.000319	0.000475	CcSEcCtD
Tretinoin—Abdominal pain—Prednisone—Crohn's disease	0.000317	0.000473	CcSEcCtD
Tretinoin—Body temperature increased—Prednisone—Crohn's disease	0.000317	0.000473	CcSEcCtD
Tretinoin—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000316	0.00543	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—PTRF—Crohn's disease	0.000301	0.00517	CbGpPWpGaD
Tretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	0.000296	0.00509	CbGpPWpGaD
Tretinoin—Hypersensitivity—Prednisone—Crohn's disease	0.000296	0.000441	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000295	0.00507	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—PTRF—Crohn's disease	0.000295	0.00507	CbGpPWpGaD
Tretinoin—Asthenia—Prednisone—Crohn's disease	0.000288	0.000429	CcSEcCtD
Tretinoin—CYP4A11—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000287	0.00493	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PLA2G4F—Crohn's disease	0.000287	0.00493	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PLA2G4F—Crohn's disease	0.000287	0.00493	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PLA2G4F—Crohn's disease	0.000287	0.00493	CbGpPWpGaD
Tretinoin—Pruritus—Prednisone—Crohn's disease	0.000284	0.000423	CcSEcCtD
Tretinoin—RARA—Gene Expression—PTRF—Crohn's disease	0.000283	0.00486	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—PTRF—Crohn's disease	0.000283	0.00486	CbGpPWpGaD
Tretinoin—Diarrhoea—Prednisone—Crohn's disease	0.000275	0.000409	CcSEcCtD
Tretinoin—Dizziness—Prednisone—Crohn's disease	0.000265	0.000396	CcSEcCtD
Tretinoin—CYP1A1—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.000261	0.00448	CbGpPWpGaD
Tretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000259	0.00445	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000256	0.00439	CbGpPWpGaD
Tretinoin—Vomiting—Prednisone—Crohn's disease	0.000255	0.00038	CcSEcCtD
Tretinoin—Rash—Prednisone—Crohn's disease	0.000253	0.000377	CcSEcCtD
Tretinoin—Dermatitis—Prednisone—Crohn's disease	0.000253	0.000377	CcSEcCtD
Tretinoin—Headache—Prednisone—Crohn's disease	0.000251	0.000375	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000246	0.00422	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—ZFP36L1—Crohn's disease	0.000244	0.0042	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—MTMR3—Crohn's disease	0.000244	0.00419	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—MTMR3—Crohn's disease	0.000244	0.00419	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—MTMR3—Crohn's disease	0.000244	0.00419	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—FADS1—Crohn's disease	0.000241	0.00414	CbGpPWpGaD
Tretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	0.000239	0.00411	CbGpPWpGaD
Tretinoin—Nausea—Prednisone—Crohn's disease	0.000238	0.000355	CcSEcCtD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.000236	0.00405	CbGpPWpGaD
Tretinoin—CYP3A7—Metapathway biotransformation—GPX4—Crohn's disease	0.000228	0.00391	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—SOCS1—Crohn's disease	0.00021	0.0036	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000209	0.00359	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—DNMT3A—Crohn's disease	0.000208	0.00357	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000206	0.00354	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—ZFP36L1—Crohn's disease	0.000197	0.00338	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000195	0.00335	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—FADS1—Crohn's disease	0.00019	0.00327	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—FADS1—Crohn's disease	0.00019	0.00327	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—FADS1—Crohn's disease	0.00019	0.00327	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000188	0.00324	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000185	0.00318	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000183	0.00314	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—SMAD3—Crohn's disease	0.000181	0.00311	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—ZFP36L1—Crohn's disease	0.00018	0.0031	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—GPX4—Crohn's disease	0.000178	0.00306	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—GPX4—Crohn's disease	0.000178	0.00306	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—GPX4—Crohn's disease	0.000178	0.00306	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000177	0.00304	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000177	0.00304	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—ZFP36L1—Crohn's disease	0.000177	0.00304	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000176	0.00302	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—GCKR—Crohn's disease	0.000172	0.00295	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—GCKR—Crohn's disease	0.000172	0.00295	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—GCKR—Crohn's disease	0.000172	0.00295	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—ZFP36L1—Crohn's disease	0.000169	0.00291	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—ZFP36L1—Crohn's disease	0.000169	0.00291	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—STAT3—Crohn's disease	0.000169	0.0029	CbGpPWpGaD
Tretinoin—CYP2B6—Metapathway biotransformation—GPX4—Crohn's disease	0.000168	0.00289	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—DNMT3A—Crohn's disease	0.000168	0.00288	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000166	0.00285	CbGpPWpGaD
Tretinoin—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	0.000165	0.00283	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000163	0.0028	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.000162	0.00279	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—STAT3—Crohn's disease	0.000159	0.00272	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000158	0.00271	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000158	0.00271	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000156	0.00268	CbGpPWpGaD
Tretinoin—CYP1A1—Metapathway biotransformation—GPX4—Crohn's disease	0.000155	0.00267	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—DNMT3A—Crohn's disease	0.000153	0.00263	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000153	0.00262	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—DNMT3A—Crohn's disease	0.00015	0.00258	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000149	0.00257	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000147	0.00253	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PTRF—Crohn's disease	0.000147	0.00253	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—TNF—Crohn's disease	0.000146	0.00251	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—DNMT3A—Crohn's disease	0.000144	0.00247	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—DNMT3A—Crohn's disease	0.000144	0.00247	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	0.000143	0.00245	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—HSPA1B—Crohn's disease	0.00014	0.00241	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—TNF—Crohn's disease	0.000137	0.00236	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000135	0.00232	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000132	0.00227	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000129	0.00222	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000127	0.00218	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000127	0.00218	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000127	0.00218	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—UBE2D1—Crohn's disease	0.000123	0.00211	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000123	0.00211	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000123	0.00211	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000122	0.00209	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000121	0.00208	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—IL6—Crohn's disease	0.000118	0.00202	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	0.000116	0.00199	CbGpPWpGaD
Tretinoin—CYP1A1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000114	0.00196	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000113	0.00195	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—HSPA1B—Crohn's disease	0.000113	0.00194	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000111	0.00191	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—IL6—Crohn's disease	0.000111	0.0019	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PLA2G4F—Crohn's disease	0.00011	0.00188	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—Crohn's disease	0.000109	0.00187	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000107	0.00185	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000107	0.00185	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000105	0.00181	CbGpPWpGaD
Tretinoin—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000104	0.00179	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—HSPA1B—Crohn's disease	0.000103	0.00178	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—HSPA1B—Crohn's disease	0.000101	0.00174	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000101	0.00173	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—UBE2D1—Crohn's disease	9.92e-05	0.0017	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.82e-05	0.00169	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.76e-05	0.00168	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—HSPA1B—Crohn's disease	9.73e-05	0.00167	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—HSPA1B—Crohn's disease	9.73e-05	0.00167	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PLA2G4F—Crohn's disease	9.57e-05	0.00164	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—MTMR3—Crohn's disease	9.31e-05	0.0016	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—UBE2D1—Crohn's disease	9.24e-05	0.00159	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—UBE2D1—Crohn's disease	9.07e-05	0.00156	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.95e-05	0.00154	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—UBE2D1—Crohn's disease	8.9e-05	0.00153	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—ZFP36L1—Crohn's disease	8.83e-05	0.00152	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—SMAD3—Crohn's disease	8.81e-05	0.00151	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PLA2G4F—Crohn's disease	8.68e-05	0.00149	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—UBE2D1—Crohn's disease	8.53e-05	0.00147	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—UBE2D1—Crohn's disease	8.53e-05	0.00147	CbGpPWpGaD
Tretinoin—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	8.5e-05	0.00146	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.3e-05	0.00143	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—STAT3—Crohn's disease	8.27e-05	0.00142	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	8.22e-05	0.00141	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	8.22e-05	0.00141	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—MTMR3—Crohn's disease	8.14e-05	0.0014	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	7.79e-05	0.00134	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	7.65e-05	0.00131	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.61e-05	0.00131	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—DNMT3A—Crohn's disease	7.51e-05	0.00129	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—MTMR3—Crohn's disease	7.38e-05	0.00127	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.28e-05	0.00125	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—FADS1—Crohn's disease	7.25e-05	0.00125	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—TNF—Crohn's disease	7.15e-05	0.00123	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—SMAD3—Crohn's disease	7.1e-05	0.00122	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GPX4—Crohn's disease	6.79e-05	0.00117	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—SMAD3—Crohn's disease	6.61e-05	0.00114	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GCKR—Crohn's disease	6.56e-05	0.00113	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—SMAD3—Crohn's disease	6.49e-05	0.00112	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.46e-05	0.00111	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—SMAD3—Crohn's disease	6.37e-05	0.00109	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	6.36e-05	0.00109	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—FADS1—Crohn's disease	6.34e-05	0.00109	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—SMAD3—Crohn's disease	6.22e-05	0.00107	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.19e-05	0.00106	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—SMAD3—Crohn's disease	6.1e-05	0.00105	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—SMAD3—Crohn's disease	6.1e-05	0.00105	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.05e-05	0.00104	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GPX4—Crohn's disease	5.94e-05	0.00102	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.93e-05	0.00102	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PLA2G4F—Crohn's disease	5.83e-05	0.001	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—IL6—Crohn's disease	5.77e-05	0.000992	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—FADS1—Crohn's disease	5.75e-05	0.000988	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GCKR—Crohn's disease	5.73e-05	0.000985	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.55e-05	0.000953	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ALB—Crohn's disease	5.47e-05	0.00094	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ALB—Crohn's disease	5.47e-05	0.00094	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ALB—Crohn's disease	5.47e-05	0.00094	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—MTMR3—Crohn's disease	5.41e-05	0.00093	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GPX4—Crohn's disease	5.39e-05	0.000926	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.26e-05	0.000904	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GCKR—Crohn's disease	5.2e-05	0.000894	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—HSPA1B—Crohn's disease	5.07e-05	0.000871	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—MTMR3—Crohn's disease	4.96e-05	0.000852	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.82e-05	0.000829	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PTGS2—Crohn's disease	4.79e-05	0.000822	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTGS2—Crohn's disease	4.79e-05	0.000822	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTGS2—Crohn's disease	4.79e-05	0.000822	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	4.71e-05	0.000808	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.69e-05	0.000805	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	4.6e-05	0.00079	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.52e-05	0.000776	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—UBE2D1—Crohn's disease	4.45e-05	0.000764	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	4.35e-05	0.000747	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—FADS1—Crohn's disease	4.22e-05	0.000724	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.1e-05	0.000705	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TYK2—Crohn's disease	4.06e-05	0.000697	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—MTMR3—Crohn's disease	4e-05	0.000687	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	3.98e-05	0.000684	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GPX4—Crohn's disease	3.95e-05	0.000678	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—MTMR3—Crohn's disease	3.91e-05	0.000672	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—JAK2—Crohn's disease	3.87e-05	0.000665	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—FADS1—Crohn's disease	3.86e-05	0.000664	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GCKR—Crohn's disease	3.81e-05	0.000655	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.72e-05	0.000639	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—MTMR3—Crohn's disease	3.69e-05	0.000635	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GPX4—Crohn's disease	3.62e-05	0.000622	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—ALB—Crohn's disease	3.54e-05	0.000607	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GCKR—Crohn's disease	3.49e-05	0.0006	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—MTMR3—Crohn's disease	3.39e-05	0.000582	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.25e-05	0.000559	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	3.24e-05	0.000557	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—SMAD3—Crohn's disease	3.18e-05	0.000547	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—FADS1—Crohn's disease	3.12e-05	0.000536	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—FADS1—Crohn's disease	3.05e-05	0.000523	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GPX4—Crohn's disease	2.92e-05	0.000501	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—FADS1—Crohn's disease	2.88e-05	0.000495	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GPX4—Crohn's disease	2.85e-05	0.00049	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—STAT3—Crohn's disease	2.84e-05	0.000488	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GCKR—Crohn's disease	2.82e-05	0.000484	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MTMR3—Crohn's disease	2.76e-05	0.000474	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GCKR—Crohn's disease	2.76e-05	0.000473	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GPX4—Crohn's disease	2.7e-05	0.000463	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—FADS1—Crohn's disease	2.64e-05	0.000453	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GCKR—Crohn's disease	2.6e-05	0.000447	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GPX4—Crohn's disease	2.47e-05	0.000425	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TNF—Crohn's disease	2.46e-05	0.000422	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GCKR—Crohn's disease	2.39e-05	0.00041	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—FADS1—Crohn's disease	2.15e-05	0.000369	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.14e-05	0.000367	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ALB—Crohn's disease	2.09e-05	0.000359	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GPX4—Crohn's disease	2.01e-05	0.000346	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—IL6—Crohn's disease	1.98e-05	0.000341	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GCKR—Crohn's disease	1.94e-05	0.000334	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.86e-05	0.00032	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—Crohn's disease	1.83e-05	0.000314	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—Crohn's disease	1.82e-05	0.000314	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.82e-05	0.000312	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.71e-05	0.000293	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—Crohn's disease	1.66e-05	0.000284	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.63e-05	0.00028	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—Crohn's disease	1.6e-05	0.000274	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.49e-05	0.000256	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—Crohn's disease	1.45e-05	0.000249	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—FADS1—Crohn's disease	1.42e-05	0.000243	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.39e-05	0.000238	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPX4—Crohn's disease	1.33e-05	0.000228	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GCKR—Crohn's disease	1.28e-05	0.00022	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.21e-05	0.000209	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—Crohn's disease	1.21e-05	0.000208	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—Crohn's disease	1.11e-05	0.000191	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—Crohn's disease	1.06e-05	0.000182	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—Crohn's disease	9.73e-06	0.000167	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—Crohn's disease	8.97e-06	0.000154	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—Crohn's disease	8.77e-06	0.000151	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—Crohn's disease	8.29e-06	0.000142	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—Crohn's disease	7.85e-06	0.000135	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—Crohn's disease	7.67e-06	0.000132	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—Crohn's disease	7.6e-06	0.000131	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—Crohn's disease	7.25e-06	0.000125	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—Crohn's disease	6.65e-06	0.000114	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—Crohn's disease	6.18e-06	0.000106	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—Crohn's disease	5.41e-06	9.29e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—Crohn's disease	4.08e-06	7e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.57e-06	6.13e-05	CbGpPWpGaD
